Literature DB >> 20000867

Diagnostic utility of two case definitions for anaphylaxis: a comparison using a retrospective case notes analysis in the UK.

Michel Erlewyn-Lajeunesse1, Sandra Dymond, Ingrid Slade, Helen L Mansfield, Rosie Fish, Owen Jones, Jonathan R Benger.   

Abstract

Anaphylaxis is a clinical diagnosis with no gold-standard test. Recent case definitions have attempted to provide objective criteria for diagnosis. The aim of this study was to compare the diagnostic concordance of the Brighton Collaboration case definition (the 'Brighton' case definition) to the consensus case definition from the Second Symposium on the Definition and Management of Anaphylaxis (the 'Symposium' definition). The study setting was a hospital-based emergency department in the UK. We identified cases of anaphylaxis by physicians' discharge diagnoses over a 2-year period from 2005 to 2006, and used randomly selected cases of allergic reaction, asthma and urticaria as a control group. Data was extracted by clinicians (who were unaware of the content of either case definition), and the two case definitions were applied by Boolean operators in a Microsoft Excel spreadsheet. Concordance between the case definitions was measured using Cohen's kappa (kappa) statistic. We reviewed 128 sets of notes, with 47 cases of anaphylaxis. Brighton and Symposium definitions had sensitivities of 0.681 and 0.671, respectively, and specificities of 0.790 and 0.704, respectively. A discordant result was found in 36/128 cases (28.1%; kappa = 0.414 [95% CI 0.253, 0.574]), which represents a moderate level of agreement between case definitions. The Brighton case definition has a similar diagnostic concordance to the Symposium case definition. It does not seem to over- or underestimate cases and is sufficiently unique that the identification of an allergic trigger does not have to form part of the case definition. This will be important in the recognition of anaphylaxis resulting from the administration of drug and vaccines, where causality should be examined separately from case ascertainment.

Entities:  

Mesh:

Year:  2010        PMID: 20000867     DOI: 10.2165/11318970-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  13 in total

1.  Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.

Authors:  Jens U Rüggeberg; Michael S Gold; José-Maria Bayas; Michael D Blum; Jan Bonhoeffer; Sheila Friedlander; Glacus de Souza Brito; Ulrich Heininger; Babatunde Imoukhuede; Ali Khamesipour; Michel Erlewyn-Lajeunesse; Susana Martin; Mika Mäkelä; Patricia Nell; Vitali Pool; Nick Simpson
Journal:  Vaccine       Date:  2007-03-12       Impact factor: 3.641

2.  Anaphylaxis as an adverse event following immunisation.

Authors:  Michel Erlewyn-Lajeunesse; Jan Bonhoeffer; Jens U Ruggeberg; Paul T Heath
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

3.  Two-sided confidence intervals for the single proportion: comparison of seven methods.

Authors:  R G Newcombe
Journal:  Stat Med       Date:  1998-04-30       Impact factor: 2.373

Review 4.  A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force.

Authors:  S G Johansson; J O Hourihane; J Bousquet; C Bruijnzeel-Koomen; S Dreborg; T Haahtela; M L Kowalski; N Mygind; J Ring; P van Cauwenberge; M van Hage-Hamsten; B Wüthrich
Journal:  Allergy       Date:  2001-09       Impact factor: 13.146

5.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

6.  Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System.

Authors:  Marianne Phelan Ross; Martine Ferguson; Debra Street; Karl Klontz; Tom Schroeder; Stefano Luccioli
Journal:  J Allergy Clin Immunol       Date:  2008-01       Impact factor: 10.793

7.  Clinical features and severity grading of anaphylaxis.

Authors:  Simon G A Brown
Journal:  J Allergy Clin Immunol       Date:  2004-08       Impact factor: 10.793

8.  National study of US emergency department visits for acute allergic reactions, 1993 to 2004.

Authors:  Theodore J Gaeta; Sunday Clark; Andrea J Pelletier; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2007-04       Impact factor: 6.347

9.  Population-based drug-related anaphylaxis in children and adolescents captured by South Carolina Emergency Room Hospital Discharge Database (SCERHDD) (2000-2002).

Authors:  Suzanne L West; Aimee A D'Aloisio; Tamar Ringel-Kulka; Anna E Waller; W Clayton Bordley
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-12       Impact factor: 2.890

10.  Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

Authors:  Hugh A Sampson; Anne Muñoz-Furlong; Ronna L Campbell; N Franklin Adkinson; S Allan Bock; Amy Branum; Simon G A Brown; Carlos A Camargo; Rita Cydulka; Stephen J Galli; Jane Gidudu; Rebecca S Gruchalla; Allen D Harlor; David L Hepner; Lawrence M Lewis; Phillip L Lieberman; Dean D Metcalfe; Robert O'Connor; Antonella Muraro; Amanda Rudman; Cara Schmitt; Debra Scherrer; F Estelle R Simons; Stephen Thomas; Joseph P Wood; Wyatt W Decker
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793

View more
  5 in total

1.  Anaphylactic reactions to local anesthetics in dental practice: a nationwide French retrospective study.

Authors:  E Hascoët; J Mahé; H Meillard; H Théophile; A Cloitre; P Lesclous
Journal:  Clin Oral Investig       Date:  2021-08-24       Impact factor: 3.573

2.  Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority.

Authors:  Inês Ribeiro-Vaz; Joana Marques; Pascal Demoly; Jorge Polónia; Eva Rebelo Gomes
Journal:  Eur J Clin Pharmacol       Date:  2012-08-23       Impact factor: 2.953

3.  Risk of anaphylaxis after vaccination in children and adults.

Authors:  Michael M McNeil; Eric S Weintraub; Jonathan Duffy; Lakshmi Sukumaran; Steven J Jacobsen; Nicola P Klein; Simon J Hambidge; Grace M Lee; Lisa A Jackson; Stephanie A Irving; Jennifer P King; Elyse O Kharbanda; Robert A Bednarczyk; Frank DeStefano
Journal:  J Allergy Clin Immunol       Date:  2015-10-06       Impact factor: 10.793

Review 4.  Vaccine-associated hypersensitivity.

Authors:  Michael M McNeil; Frank DeStefano
Journal:  J Allergy Clin Immunol       Date:  2018-02       Impact factor: 10.793

Review 5.  The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-analysis, GRADE Assessment, and International Consensus Approach.

Authors:  Matthew Greenhawt; Elissa M Abrams; Marcus Shaker; Derek K Chu; David Kahn; Cem Akin; Waleed Alqurashi; Peter Arkwright; James L Baldwin; Moshe Ben-Shoshan; Jonathan Bernstein; Theresa Bingeman; Katerina Blumchen; Aideen Byrne; Antonio Bognanni; Dianne Campbell; Ronna Campbell; Zain Chagla; Edmond S Chan; Jeffrey Chan; Pasquale Comberiatti; Timothy E Dribin; Anne K Ellis; David M Fleischer; Adam Fox; Pamela A Frischmeyer-Guerrerio; Remi Gagnon; Mitchell H Grayson; Caroline C Horner; Johnathan Hourihane; Constance H Katelaris; Harold Kim; John M Kelso; David Lang; Dennis Ledford; Michael Levin; Jay Lieberman; Richard Loh; Doug Mack; Bruce Mazer; Gissele Mosnaim; Daniel Munblit; S Shahzad Mustafa; Anil Nanda; John Oppenheimer; Kirsten P Perrett; Allison Ramsey; Matt Rank; Kara Robertson; Javed Shiek; Jonathan M Spergel; David Stukus; Mimi Lk Tang; James M Tracy; Paul J Turner; Anna Whalen-Browne; Dana Wallace; Julie Wang; Susan Wasserman; John K Witty; Margitta Worm; Timothy K Vander Leek; David Bk Golden
Journal:  J Allergy Clin Immunol Pract       Date:  2021-06-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.